ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Hua Medicine (PK)

Hua Medicine (PK) (HUMDF)

0.3401
0.00
(0.00%)
終了 6月15日 5:00AM

Hua Medicine (PK) (HUMDF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.3401
( - )
買値
0.0001
売値
84,400.52
出来高
-
0.00 日の範囲 0.00
0.3399 52 週間の範囲 0.50
時価総額
前日終値
0.3401
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 3,600,006
発行済株式数
996,519,632
配当利回り
PER
1.76
1 株当たり利益 (EPS)
1.1
歳入
492.93M
純利益
1.11B

Hua Medicine (PK) について

Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitaglip... Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China. The company develops HuaTangNing (Dorzagliatin or HMS5552), an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D and DKD. It also provides Dorzagliatin in combination with GLP1RA and small molecule GLP-1 for T2D and obesity; combination with insulin to treat insulin sparing in T2D; second generation glucokinase (GK) inhibitor and GK NAM for metabolic disease; mGLUR5 negative allosteric modulator (NAM) for PD-LID and drug addiction; and Dorzagliatin for the treatment of T2D-Drug Naïve, T2D-Metformin Tolerated, RWE study for Diabetes Remission, MODY-2, Diabetes prevention IGT2NGT, Frailty, Early AD, and CFRD. Hua Medicine (Shanghai) Ltd. was incorporated in 2011 and is headquartered in Shanghai, China. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Shanghai, China
設立
2026
Hua Medicine (PK) is listed in the Healthcare sector of the その他OTC with ticker HUMDF. The last closing price for Hua Medicine (PK) was US$0.34. Over the last year, Hua Medicine (PK) shares have traded in a share price range of US$ 0.3399 to US$ 0.50.

Hua Medicine (PK) currently has 996,519,632 shares in issue. The market capitalisation of Hua Medicine (PK) is US$338.92 million. Hua Medicine (PK) has a price to earnings ratio (PE ratio) of 1.76.

HUMDF 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.00020.05884083553990.33990.34010.3399100000.3401CS
40.00020.05884083553990.33990.34010.3399100000.3401CS
12-0.1599-31.980.50.50.3399116670.44764286CS
26-0.0706-17.19016313610.41070.50.339965210.44680834CS
52-0.0706-17.19016313610.41070.50.339931230.44675807CS
1560.137367.70216962520.20280.50.1524780.42744618CS
260-0.238-41.16934786370.57810.70.1549950.50539195CS

HUMDF - Frequently Asked Questions (FAQ)

What is the current Hua Medicine (PK) share price?
The current share price of Hua Medicine (PK) is US$ 0.3401
How many Hua Medicine (PK) shares are in issue?
Hua Medicine (PK) has 996,519,632 shares in issue
What is the market cap of Hua Medicine (PK)?
The market capitalisation of Hua Medicine (PK) is USD 338.92M
What is the 1 year trading range for Hua Medicine (PK) share price?
Hua Medicine (PK) has traded in the range of US$ 0.3399 to US$ 0.50 during the past year
What is the PE ratio of Hua Medicine (PK)?
The price to earnings ratio of Hua Medicine (PK) is 1.76
What is the cash to sales ratio of Hua Medicine (PK)?
The cash to sales ratio of Hua Medicine (PK) is 3.92
What is the registered address of Hua Medicine (PK)?
The registered address for Hua Medicine (PK) is Hua Medicine, Building 2, Lane 36, Shanghai, 201203
What is the Hua Medicine (PK) website address?
The website address for Hua Medicine (PK) is www.huamedicine.com
Which industry sector does Hua Medicine (PK) operate in?
Hua Medicine (PK) operates in the Pharmaceuticals sector

HUMDF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード